GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Brooks Laboratories Ltd (NSE:BROOKS) » Definitions » Quick Ratio

Brooks Laboratories (NSE:BROOKS) Quick Ratio : 0.93 (As of Mar. 2024)


View and export this data going back to 2011. Start your Free Trial

What is Brooks Laboratories Quick Ratio?

The quick ratio measures a company's ability to meet its short-term obligations with its most liquid assets. It is calculated as a company's Total Current Assets excludes Total Inventories divides by its Total Current Liabilities. Brooks Laboratories's quick ratio for the quarter that ended in Mar. 2024 was 0.93.

Brooks Laboratories has a quick ratio of 0.93. It indicates that the company cannot currently fully pay back its current liabilities.

The historical rank and industry rank for Brooks Laboratories's Quick Ratio or its related term are showing as below:

NSE:BROOKS' s Quick Ratio Range Over the Past 10 Years
Min: 0.37   Med: 0.56   Max: 2.13
Current: 0.93

During the past 13 years, Brooks Laboratories's highest Quick Ratio was 2.13. The lowest was 0.37. And the median was 0.56.

NSE:BROOKS's Quick Ratio is ranked worse than
64.68% of 1076 companies
in the Drug Manufacturers industry
Industry Median: 1.3 vs NSE:BROOKS: 0.93

Brooks Laboratories Quick Ratio Historical Data

The historical data trend for Brooks Laboratories's Quick Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Brooks Laboratories Quick Ratio Chart

Brooks Laboratories Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Quick Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.53 0.37 0.69 0.49 0.93

Brooks Laboratories Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Sep23 Dec23 Mar24
Quick Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - 0.49 0.83 - 0.93

Competitive Comparison of Brooks Laboratories's Quick Ratio

For the Drug Manufacturers - Specialty & Generic subindustry, Brooks Laboratories's Quick Ratio, along with its competitors' market caps and Quick Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Brooks Laboratories's Quick Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Brooks Laboratories's Quick Ratio distribution charts can be found below:

* The bar in red indicates where Brooks Laboratories's Quick Ratio falls into.



Brooks Laboratories Quick Ratio Calculation

The quick ratio measures a company's ability to meet its short-term obligations with its most liquid assets. For this reason, the ratio excludes inventories from current assets.

Brooks Laboratories's Quick Ratio for the fiscal year that ended in Mar. 2024 is calculated as

Quick Ratio (A: Mar. 2024 )=(Total Current Assets-Total Inventories)/Total Current Liabilities
=(310.483-96.108)/230.476
=0.93

Brooks Laboratories's Quick Ratio for the quarter that ended in Mar. 2024 is calculated as

Quick Ratio (Q: Mar. 2024 )=(Total Current Assets-Total Inventories)/Total Current Liabilities
=(310.483-96.108)/230.476
=0.93

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Brooks Laboratories  (NSE:BROOKS) Quick Ratio Explanation

The quick ratio is more conservative than the Current Ratio because it excludes inventories from current assets. The ratio derives its name presumably from the fact that assets such as cash and marketable securities are quick sources of cash. Inventories generally take time to be converted into cash, and if they have to be sold quickly, the company may have to accept a lower price than book value of these inventories. As a result, they are justifiably excluded from assets that are ready sources of immediate cash.

In general, low or decreasing quick ratios generally suggest that a company is over-leveraged, struggling to maintain or grow sales, paying bills too quickly or collecting receivables too slowly. On the other hand, a high or increasing quick ratio generally indicates that a company is experiencing solid top-line growth, quickly converting receivables into cash, and easily able to cover its financial obligations. Such companies often have faster inventory turnover and cash conversion cycles.

The higher the quick ratio, the better the company's liquidity position.


Brooks Laboratories Quick Ratio Related Terms

Thank you for viewing the detailed overview of Brooks Laboratories's Quick Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Brooks Laboratories (NSE:BROOKS) Business Description

Traded in Other Exchanges
Address
Off. Andheri Kurla Road, 201, The Summit Business Park, Behind Guru Nanak Petrol Pump, Andheri (East), Mumbai, MH, IND, 400 093
Brooks Laboratories Ltd is an Indian company operating in the healthcare sector. The company is engaged in the formulation, development, production, and export of drugs and pharmaceuticals. It has manufacturing sites located in Baddi, Himachal Pradesh, and Vadodara, Gujarat. It manufactures drugs in a variety of forms, including tablets, dry syrup, injections, liquid injections, dry powder injections, eye drops, and ear drops. Its products include carbapenem and penicillins.

Brooks Laboratories (NSE:BROOKS) Headlines

No Headlines